Clinical trial NCT06738732
Status: Not yet recruitingPhase 1/2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome
- Record number
- NCT06738732
- Status
- Not yet recruiting
- Type and phase
- Clinical trial, phase 1/2
- Participants
- Target: 25
- Condition (as registered)
- Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS)
- Countries
- United States
- Topic in the guide
- Dravet Syndrome, Lennox–Gastaut Syndrome
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: January 2025
- End of data collection for primary results: January 2027 (expected)
- Trial completion: January 2027 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Not yet recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Dravet Syndrome: ongoing trials · Lennox–Gastaut Syndrome: ongoing trials · Thinking of taking part? Which specialist to see